Peptic ulcer disease

A Lanas, FKL Chan - The Lancet, 2017 - thelancet.com
The rapidly declining prevalence of Helicobacter pylori infection and widespread use of
potent anti-secretory drugs means peptic ulcer disease has become substantially less …

[HTML][HTML] 25 years of proton pump inhibitors: a comprehensive review

DS Strand, D Kim, DA Peura - Gut and liver, 2017 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have
since proven to be invaluable, safe, and effective agents for the management of a variety of …

ACG clinical guideline: treatment of Helicobacter pylori infection

WD Chey, GI Leontiadis, CW Howden… - Official journal of the …, 2017 - journals.lww.com
Helicobacter pylori (H. pylori) infection is a common worldwide infection that is an important
cause of peptic ulcer disease and gastric cancer. H. pylorimay also have a role in …

Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016)

NL Jones, S Koletzko, K Goodman… - Journal of pediatric …, 2017 - journals.lww.com
Background: Because of the changing epidemiology of Helicobacter pylori infection and low
efficacy of currently recommended therapies, an update of the European Society for …

The Toronto consensus for the treatment of Helicobacter pylori infection in adults

CA Fallone, N Chiba, SV van Zanten, L Fischbach… - Gastroenterology, 2016 - Elsevier
Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

Perforated peptic ulcer

K Søreide, K Thorsen, EM Harrison, J Bingener… - The Lancet, 2015 - thelancet.com
Perforated peptic ulcer is a common emergency condition worldwide, with associated
mortality rates of up to 30%. A scarcity of high-quality studies about the condition limits the …

Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению дискинезии желчевыводящих путей

ВТ Ивашкин, ИВ Маев, ЮО Шульпекова… - Российский журнал …, 2018 - gastro-j.ru
Рос журн гастроэнтерол гепатол колопроктол 2018; 28 (3)/Rus J Gastroenterol Hepatol
Coloproctol 2018; 28 (3) путей и вторичным нарушением сократимости; возможно …

[HTML][HTML] Primer for development of guidelines for Helicobacter pylori therapy using antimicrobial stewardship

DY Graham, JM Liou - Clinical Gastroenterology and Hepatology, 2022 - Elsevier
We provide a primer to assist in the difficult transition of Helicobacter pylori therapy
guidelines to those that adhere to the principles of antimicrobial stewardship. This transition …

Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis

BZ Li, DE Threapleton, JY Wang, JM Xu, JQ Yuan… - Bmj, 2015 - bmj.com
Objective To determine the most efficacious treatment for eradication of Helicobacter pylori
with the lowest likelihood of some common adverse events among pre-recommended and …

Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients

AG McNicholl, DS Bordin, A Lucendo… - Clinical …, 2020 - Elsevier
Background & Aims Due to the poor eradication rates of standard triple therapy, the addition
of bismuth salts has been proposed for first-line eradication of Helicobacter pylori. We …